1 option
Endothelial Metabolism in Glioblastoma Vascularity and Resistance to Immunotherapy / Duo Zhang.
- Format:
- Book
- Thesis/Dissertation
- Author/Creator:
- Zhang, Duo, author.
- Language:
- English
- Subjects (All):
- Oncology.
- Biology.
- Molecular biology.
- Immunology.
- Cell and Molecular Biology--Penn dissertations.
- Penn dissertations--Cell and Molecular Biology.
- Local Subjects:
- Oncology.
- Biology.
- Molecular biology.
- Immunology.
- Cell and Molecular Biology--Penn dissertations.
- Penn dissertations--Cell and Molecular Biology.
- Physical Description:
- 1 online resource (104 pages)
- Distribution:
- Ann Arbor : ProQuest Dissertations & Theses, 2023
- Contained In:
- Dissertations Abstracts International 84-12B.
- Place of Publication:
- [Philadelphia, Pennsylvania] : University of Pennsylvania, 2022.
- Language Note:
- English
- Summary:
- Glioblastoma (GBM) stands as the most prevalent and lethal primary brain tumor. Despite recent breakthroughs in immunotherapy, specifically with chimeric antigen receptor (CAR)-modified T cells, the prognosis for GBM patients remains largely unchanged. A key factor contributing to this limited progress is the unique vascular microenvironment within GBM tumors, characterized by hypoxia and abnormal angiogenesis, which hinders the efficacy of immunotherapeutic approaches due to their inaccessibility. In this study, we present evidence that the enzyme phosphoglycerate dehydrogenase (PHGDH) plays a crucial role in endothelial cell (EC) metabolism, driving the formation of a hypoxic and immune-resistant vascular microenvironment in GBM. This, in turn, leads to a diminished response to CAR-T cell immunotherapy. By conducting comprehensive metabolome and transcriptome analyses of human and mouse GBM tumors, we discovered that PHGDH expression and serine metabolism are predominantly altered in tumor ECs. We found that tumor microenvironmental cues induce activating transcription factor 4 (ATF4)-mediated PHGDH expression in ECs, initiating a redox-dependent mechanism that modulates endothelial glycolysis and results in EC overgrowth. Importantly, by genetically ablating PHGDH in ECs, we observed a reduction in excessive vasculature, alleviation of intratumoral hypoxia, and enhanced T cell infiltration within tumors. Inhibition of PHGDH also bolstered anti-tumor T cell immunity and increased the susceptibility of GBM to CAR T therapy. In conclusion, our findings indicate that targeting PHGDH to reprogram endothelial metabolism offers a novel and promising avenue for improving T cell-based immunotherapy in GBM. Further investigation of this approach may ultimately lead to better treatment options and outcomes for patients with this aggressive and difficult-to-treat malignancy.
- Notes:
- Source: Dissertations Abstracts International, Volume: 84-12, Section: B.
- Advisors: Fan, Yi; Committee members: Conn, Crystal S.; Wellen, Kathryn E.; Kahn, Mark L.; Milone, Michael C.
- Department: Cell and Molecular Biology.
- Ph.D. University of Pennsylvania 2023.
- Local Notes:
- School code: 0175
- ISBN:
- 9798379751654
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.